연구동향 분석

도파민/세로토닌 길항성 비정형 항정신병약물로 치료 중인 정신분열병 환자에서 체중 증가의 관련 요인

김신겸 장원석 최경숙 박동연 한우상 이동수 홍경수 2004년

논문상세정보
인용/피인용
' 도파민/세로토닌 길항성 비정형 항정신병약물로 치료 중인 정신분열병 환자에서 체중 증가의 관련 요인' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
452 0

0.0%

' 도파민/세로토닌 길항성 비정형 항정신병약물로 치료 중인 정신분열병 환자에서 체중 증가의 관련 요인' 의 참고문헌

  • 항정신병약물을 투여받은 정신분열병 환자의 체중, BMI 및 혈장 Leptin 농도의 변화
    김봉조 김재종 박철수 변기욱 손진욱 항정신병약물을 투여받은 정신분열병 환자의 체중 [2000]
  • Weightgain associated with increased food intake and low habitual activitylevel in male adolescent schizophrenic inpatients treated with olanzapine
  • Weight gain induced by clozapine
    [1995]
  • Weight gain in adolescents treatedwith risperidone and conventional antipsychotics over six months
    [1988]
  • Weight gain during neuroleptic treatment
    [1981]
  • Weight gain associated with antipsychotic drugs
    [1999]
  • Weight gain amongschizophrenic patients treated with clozapine
    [1992]
  • Treatment of negative and cognitive symptoms
    [1999]
  • The relationship betweenprolactin levels and risk of breast cancer in premenopausal women
    [1987]
  • The positive and negative syndrome scale(PANS)for schizophrenia
    [1987]
  • Prolactinoma and body weight:a retrospective study
    이재호 [1991]
  • Prolactin directlyinhibits basal as well as gonadotropin-stimulated secretion ofprogesterone and 17(beta)-estradiol in the human ovary
    이재호 [1982]
  • Prevalence of obesity in outpatientsreceiving antipsychotic drug correlation with serum prolactin levels
    이은미 [1988]
  • Olanzapine을투여 받은 정신분열병 환자의 체중. 체질량지수, 렙틴, 인슐린,공복시 혈당의 변화
    권영준 김양래 박인준 우기민 정희연 조만희 Olanzapine을투여 받은 정신분열병 환자의 체중. 체질량지수 [2001]
  • Olanzapine:Weight gain and therapeutic efficacy(letter)
    유현옥 [1999]
  • Novel antipsychotics:Comparison of weight gainliabilities
  • Neuropsychological changein patients with schizophrenia after treatment with quetiapine orhaloperidol
    오욱환 [2001]
  • Metabolic fuel and reproduction in femalemammals
    신용배 [1992]
  • Medical hazards of obesity
    신명희 [1993]
  • Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia
    서혜순 [2001]
  • Kaplan & Sadock’s Synopsis of Psychiatry
    법무부 [2003]
  • Induction of obesity by psychotropic drug
    박영순 [1987]
  • Hypothalamic dopamine andserotonin in the regulation of food intake
    문수진 [2000]
  • Health risks and treatment implications
    노종희 [1983]
  • Gonadal effect on food intake and adiposity:ametabolic hypothesis
    [1979]
  • Glucoseintolerance with atypical antipsychotics
    나일주 [2002]
  • Food intake and energy balance inDiabetes Mellitus
    김태근 [1997]
  • Factors influencing acute weight change in patients with schizophreniatreated with olanzapine,haloperidol,or risperidone
    김종선 Factors influencing acute weight change in patients with schizophreniatreated with olanzapine [2001]
  • Endocrine and psychological evaluation of women with recentweight gain
    김영민 [1995]
  • Elevated levels of insulin,leptin,and blood lipid in olanzapine-treated patients with schizophreniaor related psychoses
    김시연 Elevated levels of insulin [2000]
  • Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior: possible mechanismof action
    김세훈 [2000]
  • Effect of cyproheptadineon the feeding and satiety center in the rat
    김동연 [1973]
  • Effect of chlorpromazine on bloodglucose and plasma insulin in man
    김도원 [1977]
  • Differential effect ofclozapine on weight:A controlled study
    권선숙 [1996]
  • Diagnostic and statistical manual of mental disorders (4th ed.)
  • Diagnostic and Statistical Manual of Mental Disorder
  • Diabetes mellitusin schizophrenia patients
  • Determinant of medicationcompliance in schizophrenia:empirical and clinical findings
  • Clozapine-induced weight gain:prevalence and clinical relevance
    White [1992]
  • Clozapine, diabetes mellitus, weight gain, andlipid abnormalities: a five-year naturalistic study
    White Clozapine [2000]
  • Clozapine andbody mass change
    Whelan [1998]
  • Clinical biochemical and physiologicalstudies in cases of recurrent schizophrenia
    Vygotsky [1952]
  • Change in weight in patients receiving a
    Terman [1958]
  • Change in glucose & cholesterol levels in patientswith schizophrenia treated with typical or atypical antipsychotics
    Template [2003]
  • Body weight gain induced by antipsychotic drug:mechanismand management
    Shils [1999]
  • Body weight gain after administrationof antipsychotic drugs:correlation with leptin,insulin,andreproductive hormones
    Shilling Body weight gain after administrationof antipsychotic drugs:correlation with leptin [2000]
  • Beitrage zum verlauf des korpergewichtes bei psychosen
    Saunders P [1947]
  • Atypical antipsychotics-induceddifferences in glucose regulation in schizophrenia independent ofdifferences in adiposity
    Rosenberg [2000]
  • Antipsychotics-induced weight gain:A comprehensiveresearch synthesis
    Pratt [1999]
  • Antipsychotic-induced weight gain and therapeuticresponse:A differential association
    Prange [2002]
  • Antipsychotic metaboliceffects:weight gain,diabetes mellitus,and lipid abnormalities
    Praat Antipsychotic metaboliceffects:weight gain [2001]
  • A standardised psychiatricassessment for rating chronic psychotic patients
    Malone [1977]
  • A review of the effect of atypical antipsychotics onweight
    Lugones [2003]
  • A kinetic study of chlorpromazineon the hyperglycemic response in rat:effect of chlorpromazine onplasma glucose
    Kuhl [1988]
  • A clinical trial of the efficacy andacceptability of D-fenfluramine in the treatment of neuroleptic-inducedobesity
    Ketttner [1988]